The mutual role played by vascular remodeling and immune activation in dictating the response to immunotherapy in GB has been recently emphasized by the observation that CD4+ lymphocytes are primary actors of the so-called tumor vessel normalization [65]. This evidence concerns the gene CD4 and neoplasm.